This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
We have not encountered this problem with the tube-spacer device, and so we are grateful to Dr Johnson for bringing it to our attention. Similar to the situation with reporting the side effects of pharmacologic preparations, we need to be vigilant in detecting problems with new devices. Additonal problems may also arise with the other auxiliary aerosol-delivery systems. One hopes the manufacturers will be able and willing to correct these problems.
Tobin MJ. Spacer Inhalers-Reply. Arch Intern Med. 1986;146(4):805–809. doi:10.1001/archinte.1986.00360160261041
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.